Prescription drug · ANDA
Losartan Potassium (losartan) NDC 70010-742
Losartan potassium 50 mg/1 · Tablet · Oral · Granules Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70010-742-03 | 70010074203 | 30 TABLET in 1 BOTTLE (70010-742-03)Marketed from Mar 8, 2023 | |
| 70010-742-09 | 70010074209 | 90 TABLET in 1 BOTTLE (70010-742-09)Marketed from Mar 8, 2023 | |
| 70010-742-10 | 70010074210 | 1000 TABLET in 1 BOTTLE (70010-742-10)Marketed from Mar 8, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Losartan Potassium
- Generic name (nonproprietary)
- losartan
- Active ingredients
- Losartan potassium — 50 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215959
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin 2 Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 70010-742_451da3de-077d-522d-e063-6394a90a3537SPL ID 451da3de-077d-522d-e063-6394a90a3537SPL set ID ca012edc-923d-4ada-a261-db82b71b3c4fRxCUI 979480, 979485, 979492UNII 3ST302B24A
- Pharmacologic class
- Angiotensin 2 Receptor Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470010074203followed by a unit qualifier and the quantityPackage 70010-0742-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Losartan potassium tablet is an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy. There is evidence that this benefit does not apply to Black patients. ( 1.2 ) Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria in patients with type 2 diabetes and a history of hypertension. ( 1.3 ) 1.1 Hypertension Losartan potassium tablets a…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 215959
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Losartan Potassiumlosartan | Losartan potassium 50 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4160 |
| Losartan Potassiumlosartan | Losartan potassium 100 mg/1 | TabletOral | Granules India Ltd | 62207-743 |
| Losartan Potassiumlosartan | Losartan potassium 25 mg/1 | TabletOral | Granules India Ltd | 62207-741 |
| Losartan Potassiumlosartan | Losartan potassium 50 mg/1 | TabletOral | Granules India Ltd | 62207-742 |
| Losartan Potassiumlosartan | Losartan potassium 25 mg/1 | TabletOral | Granules Pharmaceuticals Inc. | 70010-741 |
| Losartan Potassiumlosartan | Losartan potassium 100 mg/1 | TabletOral | Granules Pharmaceuticals Inc. | 70010-743 |